Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar;26(3):118-24.
doi: 10.1016/j.tem.2014.12.004. Epub 2015 Jan 15.

Functional genomics of PCOS: from GWAS to molecular mechanisms

Affiliations
Review

Functional genomics of PCOS: from GWAS to molecular mechanisms

Jan M McAllister et al. Trends Endocrinol Metab. 2015 Mar.

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrinopathy characterized by increased ovarian androgen biosynthesis, anovulation, and infertility. PCOS has a strong heritable component based on familial clustering and twin studies. Genome-wide association studies (GWAS) identified several PCOS candidate loci including LHCGR, FSHR, ZNF217, YAP1, INSR, RAB5B, and C9orf3. We review the functional roles of strong PCOS candidate loci focusing on FSHR, LHCGR, INSR, and DENND1A. We propose that these candidates comprise a hierarchical signaling network by which DENND1A, LHCGR, INSR, RAB5B, adapter proteins, and associated downstream signaling cascades converge to regulate theca cell androgen biosynthesis. Future elucidation of the functional gene networks predicted by the PCOS GWAS will result in new diagnostic and therapeutic approaches for women with PCOS.

Keywords: GWAS; PCOS; genomics; hyperandrogenism; signaling; theca.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Hypothetical model of a GWAS Signaling Cascades involved in PCOS
The schematic shows a putative network of genes postulated to contribute to the hyperandrogenimia associated with PCOS, based on the loci identified in published GWAS and replication studies (GWAS candidates are labeled in rust). The GWAS loci associated with PCOS include: 1) plasma membrane receptors (LHCGR, FSHR INSR); 2) proteins associated with protein trafficking, endocytotic processes, and receptor recycling (DENND1A, RAB5B); and 3) transcription factors (ZNF217, YAP1, TOX3, HMG). The LH/hCG receptor, FSH-receptor, and insulin receptor are all plasma membrane receptors, which are internalized/recycled by clathrin coated pits [20]. DENND1A encodes the plasma membrane protein connecdenn 1, which is involved in clathrin-binding, endocytic processes and receptor recycling [65, 74, 86]. Ras related protein 5B (RAB5B) is a Rab-GTPase, and is also involved in membrane trafficking, endocytosis and receptor recycling [87, 88]. Yes-associated protein (YAP1), transcriptional coactivator of the p300/CBP-mediated transcription complex (TOX3), high mobility group AT-hook 2 (HMGA2), and zinc finger protein 217 (ZNF217) have all be shown to be involved in transcriptional activation/repression [–77, 89]. Abbreviations: PCOS, polycystic ovary syndrome; GWAS, Genome Wide Association Study; DENND1A, connecdenn 1; DENND1A.V2, DENND1A variant 2; LHCGR, LH/CG receptor; YAP1, Yes-associated protein; TOX3, transcriptional coactivator of the p300/CBP-mediated transcription complex; HMGA2, high mobility group AT-hook 2; ZNF217, zinc finger protein 217; RAB5B, ras related protein 5B; INSR, insulin receptor; CYP17A1, cytochrome P450 17α-hydroxylase CYP11A1, cytochrome P450 cholesterol side chain cleavage.

References

    1. Azziz R, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. The Journal of Clinical Endocrinology and Metabolism. 2006;91:4237–4245. - PubMed
    1. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Human Reproduction. 2004;19:41–47. - PubMed
    1. De Leo V, et al. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome. Contraception. 2010;82:276–280. - PubMed
    1. Azziz R, et al. Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome. Fertility and Sterility. 2003;79:932–937. - PubMed
    1. Azziz R, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. The Journal of Clinical Endocrinology and Metabolism. 2001;86:1626–1632. - PubMed

Publication types